Literature DB >> 11197925

The social context of insight in schizophrenia.

R White1, P Bebbington, J Pearson, S Johnson, D Ellis.   

Abstract

BACKGROUND: Psychiatrists place great weight on impaired insight in schizophrenia, generally attributing it to pathological mental processes. However, denial of illness may be based on attitudes common in patients' social and cultural groups. Moreover, even where denial of illness has a pathological element, it may be affected by the social context. In this paper, we predicted that denial of illness would be associated with social distance between clinician and patient, and reduced by access to 'normalizing' social interaction.
METHOD: One hundred and fifty patients with schizophrenia in the London arm of the European Schizophrenia cohort were assessed using the 'Awareness of Illness' (AI) subscale of David's Assessment of Insight. Clinical and social attributes were related to AI.
RESULTS: There was little evidence for our social distance hypotheses: there was little variation in AI by social class, ethnicity, membership of a drug taking culture or the presence of strongly held religious beliefs. However, there were strong relations between AI and the size of primary group, consistent with our normalizing hypothesis.
CONCLUSIONS: The normalizing function of social support is in line with modern psychological models of delusion formation. Longitudinal data will eventually be available from the current study that will assist in establishing the causal direction of this association.

Entities:  

Mesh:

Year:  2000        PMID: 11197925     DOI: 10.1007/s001270050271

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  12 in total

Review 1.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

2.  Domains of awareness in schizophrenia.

Authors:  J Gilleen; K Greenwood; A S David
Journal:  Schizophr Bull       Date:  2010-09-17       Impact factor: 9.306

3.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

4.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

5.  Insight and its relationship with stigma in psychiatric patients.

Authors:  Deepak K Mishra; Sarika Alreja; K S Sengar; Amool R Singh
Journal:  Ind Psychiatry J       Date:  2009-01

Review 6.  Social isolation in mental health: a conceptual and methodological review.

Authors:  Jingyi Wang; Brynmor Lloyd-Evans; Domenico Giacco; Rebecca Forsyth; Cynthia Nebo; Farhana Mann; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-10-28       Impact factor: 4.328

7.  The value of doing philosophy in mental health contexts.

Authors:  Sophie Stammers; Rosalind Pulvermacher
Journal:  Med Health Care Philos       Date:  2020-12

8.  Adapting practice in mental healthcare settings during the COVID-19 pandemic and other contagions: systematic review.

Authors:  Jessica Raphael; Rachel Winter; Katherine Berry
Journal:  BJPsych Open       Date:  2021-02-26

9.  Qualitative investigation of targets for and barriers to interventions to prevent psychosis relapse.

Authors:  Emily Eisner; Christine Barrowclough; Fiona Lobban; Richard Drake
Journal:  BMC Psychiatry       Date:  2014-07-16       Impact factor: 3.630

Review 10.  [Psychopathological consequences of confinement].

Authors:  A Mengin; M C Allé; J Rolling; F Ligier; C Schroder; L Lalanne; F Berna; R Jardri; G Vaiva; P A Geoffroy; P Brunault; F Thibaut; A Chevance; A Giersch
Journal:  Encephale       Date:  2020-04-22       Impact factor: 1.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.